Health Care & Life Sciences » Biotechnology | Neuland Laboratories Ltd.

Neuland Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
4,657
4,581
4,968
5,671
5,128
Cost of Goods Sold (COGS) incl. D&A
3,517
3,666
3,852
4,336
4,309
Gross Income
1,140
916
1,116
1,335
819
SG&A Expense
540
485
588
546
652
EBIT
584
-
627
-
146
Unusual Expense
1
-
-
-
-
Non Operating Income/Expense
9
13
30
102
175
Interest Expense
236
274
245
211
189
Pretax Income
346
247
420
672
139
Income Tax
78
88
149
203
19
Consolidated Net Income
268
159
271
469
121
Net Income
268
159
273
469
121
Net Income After Extraordinaries
268
159
273
469
121
Net Income Available to Common
268
159
273
469
121
EPS (Basic)
33.50
18.67
30.76
52.75
13.58
Basic Shares Outstanding
8
9
9
9
9
EPS (Diluted)
33.49
18.66
30.75
52.75
13.58
Diluted Shares Outstanding
8
9
9
9
9
EBITDA
733
653
784
962
367
Other Operating Expense
17
70
99
19
21
Non-Operating Interest Income
8
8
7
11
8
Minority Interest Expense
1
-
2
-
-

About Neuland Laboratories

View Profile
Address
Sanali Info Park, A Block
Hyderabad TS 500034
India
Employees -
Website http://www.neulandlabs.com
Updated 09/14/2018
Neuland Laboratories Ltd. is holding company, which engages in the research, development, and commercialization of active pharmaceutical ingredients and intermediates for the generics industry. It offers custom manufacturing solutions and synthetic peptides. The company was founded by Rama Mohan Rao Davuluri on January 7, 1984 and is headquartered in Hyderabad, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.